Workflow
ModivCare (MODV) - 2023 Q3 - Quarterly Report

PART I—FINANCIAL INFORMATION Financial Statements The company's net loss widened significantly year-to-date to $199.2 million due to a major goodwill impairment, decreasing assets and creating negative operating cash flow Unaudited Condensed Consolidated Balance Sheets Total assets decreased to $1.76 billion due to a $183.1 million goodwill impairment, causing a sharp decline in stockholders' equity Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | September 30, 2023 | December 31, 2022 | Change | | :--- | :--- | :--- | :--- | | Assets | | | | | Cash and cash equivalents | $8,070 | $14,451 | ($6,381) | | Goodwill | $785,554 | $968,654 | ($183,100) | | Total assets | $1,763,086 | $1,944,272 | ($181,186) | | Liabilities & Equity | | | | | Short-term borrowings | $83,000 | $0 | +$83,000 | | Total liabilities | $1,604,225 | $1,589,716 | +$14,509 | | Retained earnings (accumulated deficit) | ($19,185) | $180,023 | ($199,208) | | Total stockholders' equity | $158,861 | $354,556 | ($195,695) | Unaudited Condensed Consolidated Statements of Operations Year-to-date revenue grew 10.7%, but a $183.1 million goodwill impairment drove a substantial net loss of $199.2 million Consolidated Statements of Operations Highlights (in thousands, except per share data) | Metric | Q3 2023 | Q3 2022 | YTD 2023 | YTD 2022 | | :--- | :--- | :--- | :--- | :--- | | Service revenue, net | $686,925 | $647,782 | $2,048,338 | $1,850,472 | | Service expense | $579,214 | $534,563 | $1,718,735 | $1,498,108 | | Impairment of goodwill | $0 | $0 | $183,100 | $0 | | Operating income (loss) | $12,043 | $12,447 | ($155,622) | $50,467 | | Net loss | ($4,302) | ($28,505) | ($199,208) | ($24,859) | | Diluted loss per share | ($0.30) | ($2.03) | ($14.06) | ($1.77) | Unaudited Condensed Consolidated Statements of Cash Flows Operating activities used $57.3 million in cash year-to-date, a sharp reversal from the prior year, necessitating short-term borrowings Cash Flow Summary (in thousands) | Activity | Nine months ended Sep 30, 2023 | Nine months ended Sep 30, 2022 | | :--- | :--- | :--- | | Net cash provided by (used in) operating activities | ($57,327) | $45,526 | | Net cash used in investing activities | ($31,143) | ($104,390) | | Net cash provided by (used in) financing activities | $82,109 | ($1,827) | | Net change in cash, cash equivalents and restricted cash | ($6,361) | ($60,691) | Notes to the Unaudited Condensed Consolidated Financial Statements Key disclosures include a $183.1 million goodwill impairment, details of the company's debt structure, and a $9.6 million legal settlement - The company operates in three main segments: Non-Emergency Medical Transportation (NEMT), Personal Care Services (PCS), and Remote Patient Monitoring (RPM)2449 - In Q2 2023, the company recorded a $183.1 million non-cash goodwill impairment charge, with $137.3 million allocated to the PCS segment and $45.8 million to the RPM segment, triggered by a decline in stock price and market volatility397275 - As of September 30, 2023, the company had $1.0 billion in senior unsecured notes and $83.0 million in outstanding short-term borrowings under its credit facility7982 - In May 2023, the company settled with its former CEO, Daniel Greenleaf, for $9.6 million regarding claims of a breach of his employment agreement100 Management's Discussion and Analysis of Financial Condition and Results of Operations Revenue growth was offset by a significant goodwill impairment and rising service expenses, tightening liquidity and increasing reliance on debt Business Outlook and Trends The company faces near-term headwinds from labor shortages and Medicaid redetermination despite positive long-term demographic trends - Long-term growth is expected from an aging population, rising chronic illnesses, and a shift towards value-based and in-home care111 - Near-term challenges include labor shortages for healthcare professionals, uncertain macroeconomic conditions, and negative impacts from Medicaid redetermination efforts110111 Results of Operations Consolidated revenue grew across all segments, but profitability was erased by a $183.1 million goodwill impairment and higher service costs NEMT Segment Key Metrics | Metric | Q3 2023 | Q3 2022 | YTD 2023 | YTD 2022 | | :--- | :--- | :--- | :--- | :--- | | Total paid trips (thousands) | 8,824 | 8,045 | 25,761 | 22,987 | | Average monthly members (thousands) | 33,660 | 36,026 | 33,892 | 33,998 | | Service revenue, net ($M) | $485.9 | $459.8 | $1,452.4 | $1,309.4 | | Operating income ($M) | $25.7 | $25.9 | $66.8 | $84.3 | PCS Segment Key Metrics | Metric | Q3 2023 | Q3 2022 | YTD 2023 | YTD 2022 | | :--- | :--- | :--- | :--- | :--- | | Total hours (thousands) | 6,995 | 6,836 | 20,752 | 20,076 | | Service revenue per hour | $25.73 | $24.76 | $25.75 | $24.49 | | Service expense per hour | $20.45 | $19.42 | $20.13 | $18.90 | | Operating income (loss) ($M) | $4.3 | $2.3 | ($118.0) | $10.3 | RPM Segment Key Metrics | Metric | Q3 2023 | Q3 2022 | YTD 2023 | YTD 2022 | | :--- | :--- | :--- | :--- | :--- | | Average monthly members (thousands) | 247 | 230 | 241 | 201 | | Service revenue, net ($M) | $19.8 | $18.8 | $57.7 | $49.4 | | Operating income (loss) ($M) | $1.0 | $0.6 | ($43.1) | ($0.2) | Liquidity and Capital Resources A significant decrease in operating cash flow to a $57.3 million deficit necessitated drawing $83.0 million from the credit facility - Cash used in operating activities was $57.3 million for YTD 2023, a decrease of $102.9 million compared to cash provided by operating activities of $45.5 million for YTD 2022180183 - The company had $83.0 million of short-term borrowings outstanding on its Credit Facility as of September 30, 2023, with approximately $164.0 million of remaining availability185188 Future Cash Requirements Summary (in thousands) | Obligation | Total | Less than 1 Year | Greater than 1 Year | | :--- | :--- | :--- | :--- | | Senior Unsecured Notes & Interest | $1,213,996 | $56,847 | $1,157,149 | | Short-term borrowings | $83,000 | $83,000 | $0 | | Operating leases | $42,299 | $8,902 | $33,397 | | Other current cash obligations | $515,888 | $515,888 | $0 | | Total | $1,936,859 | $691,662 | $1,245,197 | Quantitative and Qualitative Disclosures About Market Risk The company's primary market risk is interest rate exposure from its $83.0 million in variable-rate borrowings - The company is exposed to interest rate risk from its Credit Facility, which has variable interest rates; at September 30, 2023, $83.0 million was outstanding194 - A sensitivity analysis indicates that a one-percentage point increase in interest rates would negatively impact pre-tax earnings by approximately $0.8 million annually194 Controls and Procedures Disclosure controls were deemed ineffective as of September 30, 2023, due to previously identified material weaknesses under remediation - The principal executive and financial officers concluded that disclosure controls and procedures were not effective as of September 30, 2023, due to previously identified material weaknesses195 - Ongoing remediation efforts are focused on key areas including general IT controls (GITC), payroll controls, revenue process controls, and risk assessment197199 - Management expects that testing the operating effectiveness of the remediation plan will extend into 2024 for the PCS segment202 PART II—OTHER INFORMATION Legal Proceedings Ongoing legal matters are not expected to have a material adverse effect on the company's financial condition or operations - The company is subject to legal proceedings in the ordinary course of business but does not expect them to have a material adverse effect205 Risk Factors No material changes were reported from the risk factors disclosed in the 2022 Annual Report on Form 10-K - No material changes have occurred to the risk factors disclosed in the company's 2022 Annual Report on Form 10-K206 Unregistered Sales of Equity Securities and Use of Proceeds The company reported no unregistered sales of equity securities during the reporting period - None208 Defaults Upon Senior Securities The company reported no defaults upon its senior securities during the reporting period - None209 Other Information No officers or directors adopted or terminated Rule 10b5-1 trading plans during the third quarter - No officers or directors adopted or terminated a Rule 10b5-1 trading plan during the third quarter of 2023211 Exhibits This section indexes all exhibits filed with the Form 10-Q, including certifications and corporate documents